Glucose and insulin responses to dietary chromium supplements: a meta-analysis.

BACKGROUND Several authors, mostly on the basis of nonrandomized studies, have suggested dietary trivalent chromium supplementation as an attractive option for the management of type 2 diabetes and for glycemic control in persons at high risk of type 2 diabetes. OBJECTIVE The study aimed to determine the effect of chromium on glucose and insulin responses in healthy subjects and in individuals with glucose intolerance or type 2 diabetes. DESIGN The study design was a systematic review and meta-analysis of randomized clinical trials (RCTs). RESULTS The authors identified 20 reports of RCTs assessing the effect of chromium on glucose, insulin, or glycated hemoglobin (Hb A(1c)). This review summarizes data on 618 participants from the 15 trials that reported adequate data: 193 participants had type 2 diabetes and 425 were in good health or had impaired glucose tolerance. The meta-analysis showed no association between chromium and glucose or insulin concentrations among nondiabetic subjects. A study of 155 diabetic subjects in China showed that chromium reduced glucose and insulin concentrations; the combined data from the 38 diabetic subjects in the other studies did not. Three trials reported data on Hb A(1c): one study each of persons with type 2 diabetes, persons with impaired glucose tolerance, and healthy subjects. The study of diabetic subjects in China was the only one to report that chromium significantly reduced Hb A(1c). CONCLUSIONS Data from RCTs show no effect of chromium on glucose or insulin concentrations in nondiabetic subjects. The data for persons with diabetes are inconclusive. RCTs in well-characterized, at-risk populations are necessary to determine the effects of chromium on glucose, insulin, and Hb A(1c).

[1]  M. Hellerstein.  Is chromium supplementation effective in managing type II diabetes? , 2009, Nutrition reviews.

[2]  H. Preuss,et al.  Effects of niacin‐bound chromium supplementation on body composition in overweight African‐American women , 1999, Diabetes, obesity & metabolism.

[3]  R. Anderson.  Chromium and diabetes. , 1999, Nutrition.

[4]  W. Evans,et al.  Effect of resistance training with or without chromium picolinate supplementation on glucose metabolism in older men and women. , 1999, Metabolism: clinical and experimental.

[5]  N. Bryden,et al.  Reversal of corticosteroid‐induced diabetes mellitis with supplemental chromium , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[6]  R. Anderson,et al.  Chromium, glucose intolerance and diabetes. , 1998, Journal of the American College of Nutrition.

[7]  M. Bemben,et al.  Chromium picolinate effects on body composition and muscular performance in wrestlers. , 1998, Medicine and science in sports and exercise.

[8]  W. Mertz.  Interaction of chromium with insulin: a progress report. , 1998, Nutrition reviews.

[9]  Richard A. Anderson,et al.  Elevated Intakes of Supplemental Chromium Improve Glucose and Insulin Variables in Individuals With Type 2 Diabetes , 1997, Diabetes.

[10]  R. M. Chandler,et al.  Chromium and exercise training: effect on obese women. , 1997, Medicine and science in sports and exercise.

[11]  F. Nielsen.  Controversial Chromium: Does the Superstar Mineral of the Mountebanksa Receive Appropriate Attention from Clinicians and Nutritionists? , 1996 .

[12]  B. E. Wilson,et al.  Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. , 1995, Diabetes research and clinical practice.

[13]  N. A. Lee,et al.  Beneficial Effect of Chromium Supplementation on Serum Triglyceride Levels in NIDDM , 1994, Diabetes Care.

[14]  K. Dickersin,et al.  Systematic Reviews: Identifying relevant studies for systematic reviews , 1994 .

[15]  Richard A. Anderson,et al.  Lipid-lowering effect of a dietary chromium (III): nicotinic acid complex in male athletes , 1993 .

[16]  M. Laakso,et al.  Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels , 1992, British Journal of Nutrition.

[17]  A. S. Abraham,et al.  The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. , 1992, Metabolism: clinical and experimental.

[18]  R. Anderson.  Essentiality of chromium in humans. , 1989, The Science of the total environment.

[19]  M. Zemel,et al.  Evidence for synergism between chromium and nicotinic acid in the control of glucose tolerance in elderly humans. , 1987, Metabolism: clinical and experimental.

[20]  M. Polansky,et al.  Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. , 1987, Metabolism: clinical and experimental.

[21]  E. Offenbacher,et al.  The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids, and plasma chromium in elderly subjects. , 1985, The American journal of clinical nutrition.

[22]  R. Gibson,et al.  Dietary chromium and effect of chromium supplementation on glucose tolerance of elderly Canadian women , 1985 .

[23]  M. Polansky,et al.  Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. , 1983, Metabolism: clinical and experimental.

[24]  Mossop Rt.  Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics. , 1983 .

[25]  M. Albrink,et al.  Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. , 1981, The American journal of clinical nutrition.

[26]  T C Chalmers,et al.  A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.

[27]  E. Offenbacher,et al.  Beneficial Effect of Chromium-rich Yeast on Glucose Tolerance and Blood Lipids in Elderly Subjects , 1980, Diabetes.

[28]  J. Fischer,et al.  Chromium deficiency during total parenteral nutrition. , 1979, JAMA.

[29]  G. Greenberg,et al.  Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. , 1977, The American journal of clinical nutrition.

[30]  L. Sherman,et al.  Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. , 1968, Metabolism: clinical and experimental.

[31]  W. Glinsmann,et al.  Effect of trivalent chromium on glucose tolerance. , 1966, Metabolism: clinical and experimental.

[32]  A. Prasad.  Trace Elements in Human Health and Disease , 2003 .

[33]  F. Nielsen.  Importance of making dietary recommendations for elements designated as nutritionally beneficial, pharmacologically beneficial, or conditioinally essential , 2000 .

[34]  W. Cefalu,et al.  Effect of chromium picolinate on insulin sensitivity in vivo , 1999 .

[35]  H. Lukaski.  Chromium as a supplement. , 1999, Annual review of nutrition.

[36]  L. Jovanovič,et al.  Chromium supplementation for women with gestational diabetes mellitus , 1999 .

[37]  G. Fox,et al.  Chromium picolinate supplementation for diabetes mellitus. , 1998, The Journal of family practice.

[38]  R. Anderson.  Recent advances in the clinical and biochemical manifestation of chromium deficiency in human and animal nutrition , 1998 .

[39]  M. Westerterp-Plantenga,et al.  The effectiveness of long-term supplementation of carbohydrate, chromium, fibre and caffeine on weight maintenance , 1997, International Journal of Obesity.

[40]  S. Kapoor,et al.  Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium-51 and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels , 1979 .

[41]  D. Streeten,et al.  29 – Chromium Metabolism in Man and Biochemical Effects , 1976 .